Bu Xiang Pharmaceutical (603858.SH) released its semi-annual performance report, with a net profit attributable to shareholders of 628 million yuan, a year-on-year increase of 171.24%.

date
27/08/2025
Zhtng cijng APP xn, bchng zhyo (603858.SH) pl 2025 nin bnnin do bogo, bogo q gngs shxin yngshu 56.64 y yun, tngb zngzhng 4.27%; gum jngl 6.28 y yun, tngb zngzhng 171.24%; ku fi jngl 6.19 y yun, tngb zngzhng 180.04%; jbn mi g shuy 0.5934 yun. Gngs n mi 10 g pif xinjn hngl rnmnb 3.90 yun (hnshu).